OTTOBOCK
Ottobock creates the Exopulse Mollii Suit. Using electrical impulses, the garment relaxes muscles that are tense. They use their suits for Relaxing spastic muscles, Relaxing tense and spastic muscles, Activating muscles, Increasing local blood circulation, and Relieving symptoms of chronic pain.
OTTOBOCK
Industry:
Health Care Hospital Medical Medical Device
Founded:
2009-01-01
Address:
Danderyd, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.exopulse.com
Total Employee:
11+
Status:
Active
Contact:
+46 84700378
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Apache DoubleClick.Net
Official Site Inspections
http://www.exopulse.com Semrush global rank: 7.17 M Semrush visits lastest month: 580
- Host name: media.ottobock.com
- IP address: 194.31.240.153
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Ottobock"
ExoXpert - The exosome specialized CDMO with a GMP platform
We are an exosome specialized CDMO (Contract Development & Manufacturing Organization) offering flexible & approved platform enabling clinical trial access. Exosome vials. Buying off โฆSee details»
Exopulse Company Profile 2024: Valuation, Investors ... - PitchBook
Exopulse General Information Description. Developer of neurorehabilitation suit designed to reduce spasticity from a neurological disorder. The company's suit uses electrotherapy to โฆSee details»
ExoXpert, a CDMO launched by EXO Biologics to service increasing ...
Jan 31, 2024 ExoXpert has an exosome manufacturing plant with Grade A/B and C clean rooms, highly specialist staff and management. ExoXpert will utilize the ExoPulse manufacturing โฆSee details»
Exopulse Mollii Suit | Wearable, Near Full-Body Spasticity Relief
The Exopulse Mollii Suit is designed for people with spasticity: a movement disorder that can be related to a number of different neurological conditions and injuries. Itโs a near full-body โฆSee details»
Reduces spasticity and pain. Activates muscles.
Sep 19, 2024 The Exopulse Suit has two rechargeable control units that are easy to attach to the jacket or trousers via docking stations. A newly developed app is used to adjust the โฆSee details»
Media information: Exopulse - Ottobock
To help him learn how to move independently and safely at home, Justus wears the Exopulse Mollii Suit for one hour a day based on the recommendations given to him by his therapist. โฆSee details»
Ottobock - Crunchbase Company Profile & Funding
Organization. Ottobock . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Ottobock is a medical device provider. Danderyd, โฆSee details»
Rehacare 2024: Ottobock presents integrated treatment approach
Sep 4, 2024 New generation of the Exopulse Suit . Ottobock will premiere the next generation of the Exopulse Suit at Rehacare 2024. The new suit features an enhanced design and electrode โฆSee details»
CDMO launched to service increasing demand for exosomes
Feb 5, 2024 During the development of its lead exosome candidate, EXOB-001, Exo Biologics developed ExoPulse, an industrial exosome manufacturing platform designed for GMP โฆSee details»
How EXO Biologics plans to revolutionize exosome therapy
May 28, 2024 The company will also enhance reinforce ExoXpert, a newly launched subsidiary specializing in contract development and manufacturing organization (CDMO) services for โฆSee details»
Exopulse - Products, Competitors, Financials, Employees, โฆ
Exopulse specializes in assistive medical devices, focusing on the development and sale of the Exopulse Mollii Suit for individuals with neurological conditions. The Exopulse Mollii Suit is a โฆSee details»
Exo Biologics Secures up to EUR 16 Million in Series a Funding for ...
Apr 30, 2024 EXO Biologics, a clinical-stage biotech and a pioneer in developing exosome-based therapies, today announces the successful securing of a total of up to EUR 16 million in โฆSee details»
ExoXpert and Neucore Bio Collaborate to Optimize Exosome โฆ
Apr 19, 2024 ExoPulse is ExoXpertโs latest exosome-based therapeutic platform, currently used in clinical trials, and has been specifically designed to facilitate the production and loading of โฆSee details»
Exopulse Mollii Suit | Helps reduce spasticity and muscles
The Exopulse Mollii Suit fundamentally changes the treatment field of neurological disorders and related symptoms. It is a neuromodulation suit that makes use of a physiological reflex โฆSee details»
Innovation for MS patients: a superhero suit with 58 ... - Ottobock
Jan 11, 2023 Developed in Sweden, the Exopulse Mollii Suit is a world first and works on the principle of reciprocal inhibition for spasticity-related muscle tension. In doing so, the suit helps โฆSee details»
Discover the Exopulse Mollii Suit - Ottobock
The Exopulse Mollii Suit uses a proprietary, customizable stimulation pattern to release spastic muscles by reactivating their weakened antagonists, using a technique called reciprocal โฆSee details»
ExoXpert A CDMO Launched By EXO Biologics To Service โฆ
Jan 31, 2024 ExoXpert has an exosome manufacturing plant with Grade A/B and C clean rooms, highly specialist staff and management. ExoXpert will utilize the ExoPulse manufacturing โฆSee details»
Explaining the Exopulse Mollii Suit | Ottobock - YouTube
Apr 10, 2024 The Exopulse Mollii Suit is an assistive medical device that uses electrical stimulation to help pediatric and adult users with central nervous system disord...See details»
Exopulse Mollii Suit | Reduces spasticity, activates muscles.
The Exopulse Mollii Suit is designed to restore the normal, healthy balance of muscle groups throughout the body. It does so using a well-known technique called โneuromodulationโ: a โฆSee details»
The Exopulse Mollii Suit: Neuromodulation for Fibromyalgia
Effects of the TENS device, Exopulse Mollii Suit, on pain related to fibromyalgia: An open-label study. Neurophysiol Clin. 2023 Aug;53(4):102863. *The testimonials, statements, and opinions โฆSee details»